Multiple sclerosis

Great debate: Should potent and expensive MS therapy be used first line?

Two leading experts took to the stage during ANZAN ASM to debate a controversial topic in neurology - should high-expense high potency MS therapy be used first-line in patients with MS?Taking on the ‘yes’ side of the debate Associate Professor...

Two leading experts took to the stage during ANZAN ASM to debate a controversial topic in neurology - should high-expense...
Multiple sclerosis

Time to re-think ‘outdated’ MS concepts: Professor Richard Macdonell

The traditional concepts dividing MS into progressive and non-progressive disease are outdated and a potential obstacle to early treatment, according to Professor Richard Macdonell, Director of Neurology, Austin Hospital. Delivering the E Graeme Robertson Oration at ANZAN 2019 in Sydney, Professor Macdonell said his opinion...

The traditional concepts dividing MS into progressive and non-progressive disease are outdated and a potential obstacle to early treatment, according...
Medicopolitical

New ANZAN president has 3 priorities

Brisbane neurologist Professor Pamela McComb says she has there priority areas as the new president of the Australian and New Zealand Association of Neurology. Speaking at the ANZAN Annual Scientific Meeting in Sydney on 25 May, Professor McComb said workforce and...

Brisbane neurologist Professor Pamela McComb says she has there priority areas as the new president of the Australian and New...